Form 8-K Kura Oncology, Inc. For: Nov 20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- L3Harris CEO steps down amid conduct review, shares drop
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Kura Oncology (KURA) PT Lowered to $11 at Stifel
November 22, 2024 1:33 PM ESTStifel analyst Bradley Canino lowered the price target on Kura Oncology (NASDAQ: KURA) to $11.00 (from $18.00) while maintaining a Hold rating.
The analyst comments "We think KURA's stock is likely to remain range-bound. This week's ziftomenib (menin) partnership (LINK) provides enough cash for several years... More
Kura Oncology (KURA) PT Raised to $37 at H.C. Wainwright
November 21, 2024 6:35 AM ESTH.C. Wainwright analyst Joseph Pantginis raised the price target on Kura Oncology (NASDAQ: KURA) to $37.00 (from $32.00) while maintaining a Buy rating.
The analyst comments "Kyowa agreement allows ziftomenibs expansive development in frontline settings and beyond. Yesterday after the close, Kura announced a... More
